171 related articles for article (PubMed ID: 28551758)
1. Oxidation products are increased in patients affected by non-segmental generalized vitiligo.
Vaccaro M; Bagnato G; Cristani M; Borgia F; Spatari G; Tigano V; Saja A; Guarneri F; Cannavò SP; Gangemi S
Arch Dermatol Res; 2017 Aug; 309(6):485-490. PubMed ID: 28551758
[TBL] [Abstract][Full Text] [Related]
2. Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.
Di Lorenzo G; Minciullo PL; Leto-Barone MS; La Piana S; La Porta G; Saija A; Gangemi S
J Investig Allergol Clin Immunol; 2013; 23(2):101-6. PubMed ID: 23654076
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress markers are increased in patients with mastocytosis.
Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
[TBL] [Abstract][Full Text] [Related]
4. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes.
Gradinaru D; Borsa C; Ionescu C; Margina D
J Proteomics; 2013 Oct; 92():313-22. PubMed ID: 23587667
[TBL] [Abstract][Full Text] [Related]
5. Plasma markers of oxidative status were associated with increasing continuous cardiometabolic risk scores in healthy students aged 16-20 years without central obesity.
Koborová I; Gurecká R; Csongová M; Šebek J; Šebeková K
Acta Paediatr; 2018 Dec; 107(12):2137-2145. PubMed ID: 29706023
[TBL] [Abstract][Full Text] [Related]
6. Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions.
Gangemi S; Allegra A; Alonci A; Cristani M; Russo S; Speciale A; Penna G; Spatari G; Cannavò A; Bellomo G; Musolino C
Inflamm Res; 2012 Oct; 61(10):1063-7. PubMed ID: 22674324
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress markers in patients with hymenoptera venom allergy.
Patella V; Incorvaia C; Minciullo PL; Oricchio C; Saitta S; Florio G; Saija A; Gangemi S
Allergy Asthma Proc; 2015; 36(1):9-13. PubMed ID: 25562550
[TBL] [Abstract][Full Text] [Related]
8. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
[TBL] [Abstract][Full Text] [Related]
9. Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.
Gangemi S; Allegra A; Sciarrone P; Russo S; Cristani M; Gerace D; Saitta S; Alonci A; Musolino C
Eur J Haematol; 2015 Apr; 94(4):368-73. PubMed ID: 24813235
[TBL] [Abstract][Full Text] [Related]
10. Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway.
Wu Q; Zhong ZM; Zhu SY; Liao CR; Pan Y; Zeng JH; Zheng S; Ding RT; Lin QS; Ye Q; Ye WB; Li W; Chen JT
Apoptosis; 2016 Jan; 21(1):36-50. PubMed ID: 26520447
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end-products and advanced oxidation protein products levels are correlates of duration of type 2 diabetes.
Heidari F; Rabizadeh S; Rajab A; Heidari F; Mouodi M; Mirmiranpour H; Esteghamati A; Nakhjavani M
Life Sci; 2020 Nov; 260():118422. PubMed ID: 32946914
[TBL] [Abstract][Full Text] [Related]
12. [Plasma and salivary markers of oxidative and carbonyl stress in patients with acute intermittent porphyria].
Mydlík M; Derzsiová K; Koborová I; Šebeková K
Vnitr Lek; 2016; 62 Suppl 6():25-29. PubMed ID: 28124928
[TBL] [Abstract][Full Text] [Related]
13. Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation.
Cristani M; Speciale A; Saija A; Gangemi S; Minciullo PL; Cimino F
Curr Med Chem; 2016; 23(34):3862-3882. PubMed ID: 27593960
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis.
Ruggeri RM; Vicchio TM; Cristani M; Certo R; Caccamo D; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
Thyroid; 2016 Apr; 26(4):504-11. PubMed ID: 26854840
[TBL] [Abstract][Full Text] [Related]
15. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis.
Wu Q; Zhong ZM; Pan Y; Zeng JH; Zheng S; Zhu SY; Chen JT
Med Sci Monit; 2015 Aug; 21():2428-32. PubMed ID: 26286507
[TBL] [Abstract][Full Text] [Related]
16. Oxidized tyrosinase: A possible antigenic stimulus for non-segmental vitiligo autoantibodies.
Al-Shobaili HA; Rasheed Z
J Dermatol Sci; 2015 Sep; 79(3):203-13. PubMed ID: 26137927
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo.
Akoglu G; Emre S; Metin A; Akbas A; Yorulmaz A; Isikoglu S; Sener S; Kilinc F
Clin Exp Dermatol; 2013 Oct; 38(7):701-6. PubMed ID: 23601201
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.
Najafizadeh SR; Amiri K; Moghaddassi M; Khanmohammadi S; Mirmiranpour H; Nakhjavani M
Clin Rheumatol; 2021 Oct; 40(10):4019-4026. PubMed ID: 34050440
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-products and advanced oxidation protein products in schizophrenia.
Pandolfo G; Genovese G; Bruno A; Campolo D; Tigano V; Cristani M; Casciaro M; Pioggia G; Gangemi S
Psychiatry Res; 2022 May; 311():114527. PubMed ID: 35344686
[TBL] [Abstract][Full Text] [Related]
20. Advanced Oxidative Protein Products Role in Multiple Sclerosis: a Systematic Review and Meta-analysis.
Rodrigues P; Bochi GV; Trevisan G
Mol Neurobiol; 2021 Nov; 58(11):5724-5742. PubMed ID: 34392502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
